Tradestie Institutional Equity Comparison Engine

DAWN vs ACHV โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-09 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DAWN Overall Edge

DAWN Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Day One Biopharmaceuticals, Inc. Common Stock (DAWN) driven by superior Momentum & Technical, Options & Structure while ACHV counters with relative strength in Valuation, Growth & Margin. Fundamentally, DAWN trades at N/M Forward P/E with -51.1% operating margin (+83.9% YoY revenue) versus ACHV at 35.3x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, DAWN sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against ACHV sits in BREAKOUT (23rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ACHV
DAWN N/M vs ACHV 35.3x Fwd P/E
Growth & Margin Winner ACHV
Op Margin -51.1% vs 0.0% ยท YoY +83.9% vs +0.0%
Momentum & Technical Winner DAWN
1Y +201.5% vs +43.0% ยท 52W Pos 100% vs 69%
Options & Structure Winner DAWN
UNCLASSIFIED (<1st %ile IV) vs BREAKOUT (23rd %ile IV)
DAWN NASDAQ
Day One Biopharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$21.53
+0.19% 1D
Market Cap $2.2B
1M Return +0.8%
1Y Return +201.54%
Forward P/E N/M
Unified AI Score
58.3 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 66.0 Mom 46.0
ACHV NASDAQ
Achieve Life Sciences, Inc.
In Vitro & In Vivo Diagnostic Substances
$6.78
+0.89% 1D
Market Cap $692.8M
1M Return -8.5%
1Y Return +43.04%
Forward P/E 35.3x
Unified AI Score
56.6 / 100 HOLD
Tech 66.0 Fund 58.0 Flow 57.0 Mom 58.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DAWN +201.54% ACHV +43.04% Spread: +150.25 pp (DAWN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DAWN TTM Op. Margin: -51.1% ACHV TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DAWN vs ACHV. Trailing 12-month operating profitability (DAWN -51.1% vs ACHV 0.0%) and valuation multiples (DAWN N/M vs ACHV 35.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DAWN (6) vs ACHV (4)
Institutional Metric DAWN ACHV Criterion Row Winner
Market Capitalization Scale $2.2B $692.8M Larger Scale DAWN
Trailing P/E Ratio Valuation N/M 35.3x Lower Multiple ACHV
Forward P/E Ratio Valuation N/M 35.3x Lower Multiple ACHV
Revenue Growth (YoY) Growth +83.9% +0.0% Higher Growth DAWN
Operating Margin (TTM) Profitability -51.1% 0.0% Higher Margin ACHV
Net Profit Margin Profitability -67.8% 0.0% Higher Margin ACHV
Return on Equity (ROE) Capital Efficiency -22.7% -845.0% Higher ROE DAWN
52-Week Range Position Momentum 100% ($6โ€“$22) 69% ($3โ€“$9) Stronger Trend DAWN
Beta / 30D Volatility Risk Regime 0.03ฮฒ ยท 2% Vol 1.73ฮฒ ยท 62% Vol Lower Realized Risk DAWN
Unified Institutional Score Composite Signal 58.3 / 100 (HOLD) 56.6 / 100 (HOLD) Higher Composite DAWN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DAWN vs ACHV Buy Guide
DAWN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live DAWN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ACHV BREAKOUT
125d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 23rd %ile
IV Regime Compressed (<25th %ile)
Live ACHV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DAWN nor ACHV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.